Related Experiment Video
Updated: May 22, 2025
Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint
Published on: July 22, 2021
Identification and validation of transcriptome-wide association study-derived genes as potential druggable targets
Xindie Zhou1,2,3, Xinjian Ye4,5, Jiapei Yao1,2
1Department of Orthopedics, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, China.
Aims:
Osteoarthritis (OA) is a widespread chronic degenerative joint disease with an increasing global impact. The pathogenesis of OA involves complex interactions between genetic and environmental factors. Despite this, the specific genetic mechanisms underlying OA remain only partially understood, hindering the development of targeted therapeutic strategies.
Methods:
A transcriptome-wide association study (TWAS) was conducted for site-specific OA phenotypes using functional summary-based imputation (FUSION). High-confidence candidate genes were identified through rigorous quality control measures, including joint/conditional analysis, permutation tests, best model evaluation, and colocalization analysis. Co-expression network analysis was performed to elucidate the functional biology of these candidate genes. Druggable gene targets and their structural models were retrieved from the DrugBank and SWISS-MODEL databases. Finally, the enrichment of mitogen-activated protein kinase 3 (MAPK3) and SMAD3 in OA was validated biochemically using in vitro and in vivo OA models, as well as human histological sections.
Results:
Utilizing the FUSION algorithm, TWAS identified 794 candidate genes for OA. After quality control, 14 genes were classified as high-confidence genes, with seven recognized as potential drug targets including GCAT, MAPK3, MST1R, PFKM, RAD9A, SMAD3, and USAP8. Co-expression analysis revealed a strong biological association between SMAD3 and MAPK3. Both in vitro and in vivo experiments demonstrated high activity and enriched expression of these two genes in OA.
Conclusion:
The present study identified tissue-specific candidate genes and validated high-confidence druggable targets for OA, providing new insights into the genetic landscape and biological processes involved in OA. Further functional studies are warranted to confirm these findings.
Insights
This study identified key genes like MAPK3 and SMAD3 involved in osteoarthritis (OA). These findings offer new druggable targets for developing effective OA treatments.
Area of Science:
- Genetics
- Molecular Biology
- Rheumatology
Background:
- Osteoarthritis (OA) is a prevalent degenerative joint disease with complex genetic and environmental causes.
- Current understanding of OA's genetic mechanisms is incomplete, limiting targeted therapies.
Purpose of the Study:
- To identify tissue-specific candidate genes for osteoarthritis (OA).
- To validate high-confidence druggable gene targets for OA.
- To gain insights into the genetic landscape and biological processes of OA.
Main Methods:
- A transcriptome-wide association study (TWAS) using the FUSION algorithm was performed for site-specific OA.
- Rigorous quality control, including joint/conditional analysis and colocalization, identified high-confidence genes.
- Co-expression network analysis, druggable target identification (DrugBank, SWISS-MODEL), and biochemical validation of MAPK3 and SMAD3 were conducted.
Main Results:
- TWAS identified 794 candidate OA genes; 14 were high-confidence, with seven identified as potential drug targets (GCAT, MAPK3, MST1R, PFKM, RAD9A, SMAD3, USAP8).
- Co-expression analysis highlighted a strong association between SMAD3 and MAPK3.
- In vitro, in vivo, and human histological studies confirmed enriched expression and high activity of MAPK3 and SMAD3 in OA.
Conclusions:
- This research identified novel tissue-specific candidate genes and validated druggable targets for OA.
- The findings provide new insights into OA's genetic basis and biological pathways.
- Further functional studies are recommended to validate these potential therapeutic targets.
More Related Videos
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
12:44Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
Published on: January 27, 2023
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
01:20The JAK-STAT Signaling Pathway